Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Journal of Rheumatology|April 3, 2015
Direct health costs of inflammatory polyarthritis 10 years after disease onset: results from the Norfolk Arthritis RegisterElena Nikiphorou, Charlotte Davies, Miranda Mugford, et al.BMC Health Services Research|May 2, 2008
Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR)Mariamma M Thalanany, Miranda Mugford, Clare Hibbert, et al.Lancet (London, England)|September 19, 2009
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialGiles J Peek, Miranda Mugford, Ravindranath Tiruvoipati, et al.Schizophrenia Research|December 27, 2014
Comparing time use in individuals at different stages of psychosis and a non-clinical comparison groupJo Hodgekins, Paul French, Max Birchwood, et al.Pharmacoeconomics|June 17, 2010
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trialEdward C F Wilson, Erika J Sims, Stanley D Musgrave, et al.Pharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.European Journal of Public Health|February 14, 2013
Health sector costs of self-reported food allergy in Europe: a patient-based cost of illness studyMargaret Fox, Miranda Mugford, Jantine Voordouw, et al.Pageof 5